Results 111 to 120 of about 44,369 (290)
Therapy for patient with atrial fibrillation: in search of a balance between efficacy and safety
Клинический разбор в общей медицинеThis paper analyzes aspects of the efficacy and safety of antiarrhythmic drugs in the treatment of atrial fibrillation. It considers drug-drug interactions of antiarrhythmics with other drugs, especially in the near circle, i.e.
Yakov G. Bozhko +2 more
doaj +1 more source
Burden and Risk Factors of CGM‐Detected Hypoglycemia in Older Adults With Type 2 Diabetes
Journal of the American Geriatrics Society, EarlyView.Among older adults with diabetes using insulin or sulfonylureas, the median time spent in hypoglycemia was 3.4% and ~66% of participants exceeded the target of < 1% time with CGM glucose < 70 mg/dL. ABSTRACT Background Comprehensive data on the burden of biochemical hypoglycemia in older adults with type 2 diabetes are lacking.
Michael Fang +6 more
wiley +1 more source
The role of antiarrhythmic drugs in sudden cardiac death
, 1986 Antiarrhythmic drugs may either decrease or increase the likelihood of ventricular fibrillation. Although reliable data suggest reasonable mechanisms for the antiarrhythmic action of several drugs, much less information is available to indicate the ...
Dangman, Kenneth H., Hoffman, Brian F.
core +1 more source
Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010? [PDF]
Journal of Tehran University Heart Center, 2010 Atrial fibrillation (AF) is a commonly encountered arrhythmia in our daily practice. Every year a huge bulk of data is published about different management strategies, new antiarrhythmic drugs, anticoagulation protocols and ablation procedures in these ...
Mehdi Montazeri, Gholamreza Davoodi
doaj
Journal of Internal Medicine, EarlyView.Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen +11 more
wiley +1 more source
Российский кардиологический журнал, 2003 The aim of the study was to assess the influence of intravenous administration of mexicor (7mg / kg) on electrophysiological, hemodynamic action and antiarrhythmic activity of nibentan (1 mg / kg), propranolol (1,4mg / kg) and verapamil (0,4mg / kg) in ...
A. A. Kotljarov, L. N. Sernov
doaj
Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents: 2. Further Investigation
, 2016 Fifteen quinolizidine derivatives have been tested for antiarrhythmic, inotropic, and chronotropic effects on isolated guinea pig (gp) heart tissues and to assess calcium antagonist activity.
Pierfranco Ioan (137327) +9 more
core +1 more source
Journal of Small Animal Practice, EarlyView.Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon +3 more
wiley +1 more source
Modified Anatomical Ablation Strategy for Mitral Isthmus
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Background Durable mitral isthmus (MI) block remains challenging in persistent atrial fibrillation (AF) ablation. Ethanol infusion into the vein of Marshall (EI‐VOM) enhances efficacy, but the minimal endocardial ablation extent post‐EI‐VOM is undefined.
Kui He +7 more
wiley +1 more source